Table 2.

Final responsibility for the application of pharmacogenomic screening results in patient care.

Responsible Person	Community Pharmacists	Hospital Pharmacists	Physicians
Pharmacist	18 (39%)	5 (38%)	2 (9.5%)
Prescriber	10 (22%)	8 (62%)	16 (76%)
Clinical geneticist	7 (15%)	-	2 (9.5%)
General practitioner	-	-	-
Other		-
Shared responsibility in general	5 (11%)
Pharmacist and prescriber are jointly responsible	4 (9%)
Pharmacist, providing sufficient information transfer	1 (2%)
Depending on drugs prescribed	-		1 (5%)
Other	1 (2%)